Table 2.
Basic characteristics of study populations for selected 24 healthcare services
| Service category | Healthcare service | Total Number | Age (mean, sd) | Female gender | Utilization rate |
|---|---|---|---|---|---|
| Screening | Colon cancer screening | 276,387 | 58.6 (5.8) | 142,675 (51.6%) | 5.9% |
| Breast cancer screening | 178,145 | 61.0 (7.2) | – | 20.9% | |
| Prostate cancer screening | 145,874 | 59.1 (6.2) | – | 28.4% | |
| Osteoporosis screening | 97,237 | 72.5 (8.5) | 60,812 (62.5%) | 3.5% | |
| Diagnosis | DM: HbA1c test | 49,198 | 66.6 (13.0) | 22,138 (45.0%) | 69.6% |
| DM: kidney exam | 49,198 | 66.6 (13.0) | 22,138 (45.0%) | 44.3% | |
| DM: LDL test | 33,975 | 60.1 (11.2) | 13,977 (41.2%) | 44.3% | |
| DM: eye check | 49,198 | 66.6 (13.0) | 22,138 (45.0%) | 55.5% | |
| TSH | 169,232 | 56.8 (18.5) | 111,847 (66.1%) | 76.1% | |
| POCR | 47,215 | 60.3 (17.2) | 27,086 (57.4%) | 13.0% | |
| Primary prevention | Influenza vaccination | 409,960 | 64.1 (16.3) | 230,202 (56.2%) | 20.9% |
| Treatment | BZD | 243,951 | 75.0 (7.6) | 141,986 (58.2%) | 18.6% |
| PPI | 153,523 | 55.7 (17.8) | 93,543 (60.9%) | 55.5% | |
| Outpatient procedures | 10,656 | 50.5 (13.7) | 7719 (72.4%) | 61.4% | |
| C-section | 9449 | 31.9 (5.1) | – | 28.5% | |
| Secondary prevention | AMI: aspirin | 2232 | 72.4 (13.7) | 801 (35.9%) | 47.0% |
| AMI: statin | 2232 | 72.4 (13.7) | 801 (35.9%) | 34.2% | |
| AMI: beta-blocker | 2232 | 72.4 (13.7) | 801 (35.9%) | 42.1% | |
| AMI: ACE/ARB | 2232 | 72.4 (13.7) | 801 (35.9%) | 43.8% | |
| AMI: P2Y | 2232 | 72.4 (13.7) | 801 (35.9%) | 46.8% | |
| PPI with NSAID | 95,072 | 61.0 (16.2) | 60,804 (64.0%) | 43.5% | |
| PAD: statin | 23,868 | 63.6 (16.5) | 12,113 (50.7%) | 28.5% | |
| Afib: anticoagulation | 8291 | 80.8 (7.9) | 4037 (48.7%) | 27.5% | |
| GKK | 1992 | 59.2 (15.3) | 1369 (68.7%) | 58.7% |
sd Standard deviation, DM Diabetes mellitus, HbA1c Glycated hemoglobin, LDL Low-density lipoprotein, TSH Thyroid stimulating hormone, POCR Outpatient preoperative chest radiography, BZD Benzodiazepines, PPI Proton pump inhibitor, C-section Cesarean section, AMI Acute myocardial infarction, ACE Angiotensin converting enzyme, ARB Angiotensin receptor blocker, P2Y Clopidogrel, prasugrel or ticagrelor, NSAID Nonsteroidal anti-inflammatory drug, PAD Peripheral artery disease, Afib Atrial fibrillation, GKK Glucocorticoid